Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches

NCT00660192 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Refractory Migraine

Interventions

DRUG: Botox
OTHER: Placebo

Sponsor

Yale University